Covid-19 roundup: FDA reveals booster adcomm question; Eli Lilly's antibody cocktail cleared for prevention
The FDA released briefing documents this week from the agency and Pfizer each outlining their arguments for today’s Covid-19 booster shot adcomm, but one …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.